These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37558939)

  • 1. Compilation of Custom Compound/Bioactivity Datasets from Public Repositories.
    Isigkeit L; Merk D
    Methods Mol Biol; 2023; 2706():25-50. PubMed ID: 37558939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Consensus Compound/Bioactivity Dataset for Data-Driven Drug Design and Chemogenomics.
    Isigkeit L; Chaikuad A; Merk D
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Q-raKtion: A Semiautomated KNIME Workflow for Bioactivity Data Points Curation.
    Palazzotti D; Fiorelli M; Sabatini S; Massari S; Barreca ML; Astolfi A
    J Chem Inf Model; 2022 Dec; 62(24):6309-6315. PubMed ID: 36442071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity, assay and target data curation and quality in the ChEMBL database.
    Papadatos G; Gaulton A; Hersey A; Overington JP
    J Comput Aided Mol Des; 2015 Sep; 29(9):885-96. PubMed ID: 26201396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the correlations among the chemical structures, bioactivity profiles and molecular targets of small molecules.
    Cheng T; Wang Y; Bryant SH
    Bioinformatics; 2010 Nov; 26(22):2881-8. PubMed ID: 20947527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound Data Mining for Drug Discovery.
    Bajorath J
    Methods Mol Biol; 2017; 1526():247-256. PubMed ID: 27896746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the value of curation: A survey of US data repository curation practices and perceptions.
    Johnston LR; Curty R; Braxton SM; Carlson J; Hadley H; Lafferty-Hess S; Luong H; Petters JL; Kozlowski WA
    PLoS One; 2024; 19(6):e0301171. PubMed ID: 38875230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collation and data-mining of literature bioactivity data for drug discovery.
    Bellis LJ; Akhtar R; Al-Lazikani B; Atkinson F; Bento AP; Chambers J; Davies M; Gaulton A; Hersey A; Ikeda K; Krüger FA; Light Y; McGlinchey S; Santos R; Stauch B; Overington JP
    Biochem Soc Trans; 2011 Oct; 39(5):1365-70. PubMed ID: 21936816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods.
    Zdrazil B; Felix E; Hunter F; Manners EJ; Blackshaw J; Corbett S; de Veij M; Ioannidis H; Lopez DM; Mosquera JF; Magarinos MP; Bosc N; Arcila R; Kizilören T; Gaulton A; Bento AP; Adasme MF; Monecke P; Landrum GA; Leach AR
    Nucleic Acids Res; 2024 Jan; 52(D1):D1180-D1192. PubMed ID: 37933841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database.
    Wang L; Ma C; Wipf P; Liu H; Su W; Xie XQ
    AAPS J; 2013 Apr; 15(2):395-406. PubMed ID: 23292636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal chemistry in the era of big data.
    Richter L; Ecker GF
    Drug Discov Today Technol; 2015 Jul; 14():37-41. PubMed ID: 26194586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accessing Public Compound Databases with KNIME.
    Hemmerich J; Gurinova J; Digles D
    Curr Med Chem; 2020; 27(38):6444-6457. PubMed ID: 31368867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining.
    Cheng T; Li Q; Wang Y; Bryant SH
    J Chem Inf Model; 2011 Sep; 51(9):2440-8. PubMed ID: 21834535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A document classifier for medicinal chemistry publications trained on the ChEMBL corpus.
    Papadatos G; van Westen GJ; Croset S; Santos R; Trubian S; Overington JP
    J Cheminform; 2014 Dec; 6(1):40. PubMed ID: 25221627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BindingDB and ChEMBL: online compound databases for drug discovery.
    Wassermann AM; Bajorath J
    Expert Opin Drug Discov; 2011 Jul; 6(7):683-7. PubMed ID: 22650976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of repositories for sharing individual-participant data from clinical studies.
    Banzi R; Canham S; Kuchinke W; Krleza-Jeric K; Demotes-Mainard J; Ohmann C
    Trials; 2019 Mar; 20(1):169. PubMed ID: 30876434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mining the ChEMBL database: an efficient chemoinformatics workflow for assembling an ion channel-focused screening library.
    Mok NY; Brenk R
    J Chem Inf Model; 2011 Oct; 51(10):2449-54. PubMed ID: 21978256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data.
    Chen B; Dong X; Jiao D; Wang H; Zhu Q; Ding Y; Wild DJ
    BMC Bioinformatics; 2010 May; 11():255. PubMed ID: 20478034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality Issues with Public Domain Chemogenomics Data.
    Kalliokoski T; Kramer C; Vulpetti A
    Mol Inform; 2013 Dec; 32(11-12):898-905. PubMed ID: 27481136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multioutput Perturbation-Theory Machine Learning (PTML) Model of ChEMBL Data for Antiretroviral Compounds.
    Vásquez-Domínguez E; Armijos-Jaramillo VD; Tejera E; González-Díaz H
    Mol Pharm; 2019 Oct; 16(10):4200-4212. PubMed ID: 31426639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.